Philip S Macklin (Philip Macklin)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

Nature communications

The Journal of pathology

Histopathology

Proceedings of the National Academy of Sciences of the United States of America

Oxford University Hospitals NHS Foundation Trust

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oxford University Hospitals NHS Foundation Trust Jul 22 2020

United Kingdom

Specialist Trainee (Histopathology) :: Department of Cellular Pathology

Royal Berkshire Hospital Aug 07 2019 - Feb 05 2020

United Kingdom

Specialist Trainee (Histopathology) :: Department of Cellular Pathology

Publications

Mike Bogetofte Barnkob, Yale S Michaels, Violaine André, Philip S Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna A Kulicke, Ji-Li Chen, Vitul Jain, Victoria K Woodcock, Huw Colin-York, Andreas V Hadjinicolaou, Youxin Kong, Viveka Mayya, Julie M Mazet, Gracie-Jennah Mead, Joshua A Bull, Pramila Rijal, Christopher W Pugh, Alain R Townsend, Audrey Gerard, Lars Rønn Olsen, Marco Fritzsche, Tudor A Fulga, Michael L Dustin, Edith Yvonne Jones, Vincenzo Cerundolo
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8 + T cells. Nature communications 15 (1) (2024)
Mike Bogetofte Barnkob, Yale S Michaels, Violaine André, Philip S Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna A Kulicke, Ji-Li Chen, Vitul Jain, Victoria K Woodcock, Huw Colin-York, Andreas V Hadjinicolaou, Youxin Kong, Viveka Mayya, Julie M Mazet, Gracie-Jennah Mead, Joshua A Bull, Pramila Rijal, Christopher W Pugh, Alain R Townsend, Audrey Gerard, Lars Rønn Olsen, Marco Fritzsche, Tudor A Fulga, Michael L Dustin, Edith Yvonne Jones, Vincenzo Cerundolo
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8 + T cells. Nature communications 15 (1) (2024)
Mike Bogetofte Barnkob, Yale S Michaels, Violaine André, Philip S Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna A Kulicke, Ji-Li Chen, Vitul Jain, Victoria K Woodcock, Huw Colin-York, Andreas V Hadjinicolaou, Youxin Kong, Viveka Mayya, Julie M Mazet, Gracie-Jennah Mead, Joshua A Bull, Pramila Rijal, Christopher W Pugh, Alain R Townsend, Audrey Gerard, Lars Rønn Olsen, Marco Fritzsche, Tudor A Fulga, Michael L Dustin, Edith Yvonne Jones, Vincenzo Cerundolo
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8 + T cells. Nature communications 15 (1) (2024)
Mike Bogetofte Barnkob, Yale S Michaels, Violaine André, Philip S Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna A Kulicke, Ji-Li Chen, Vitul Jain, Victoria K Woodcock, Huw Colin-York, Andreas V Hadjinicolaou, Youxin Kong, Viveka Mayya, Julie M Mazet, Gracie-Jennah Mead, Joshua A Bull, Pramila Rijal, Christopher W Pugh, Alain R Townsend, Audrey Gerard, Lars Rønn Olsen, Marco Fritzsche, Tudor A Fulga, Michael L Dustin, Edith Yvonne Jones, Vincenzo Cerundolo
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8 + T cells. Nature communications 15 (1) (2024)
Mike Bogetofte Barnkob, Yale S Michaels, Violaine André, Philip S Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna A Kulicke, Ji-Li Chen, Vitul Jain, Victoria K Woodcock, Huw Colin-York, Andreas V Hadjinicolaou, Youxin Kong, Viveka Mayya, Julie M Mazet, Gracie-Jennah Mead, Joshua A Bull, Pramila Rijal, Christopher W Pugh, Alain R Townsend, Audrey Gerard, Lars Rønn Olsen, Marco Fritzsche, Tudor A Fulga, Michael L Dustin, Edith Yvonne Jones, Vincenzo Cerundolo
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8 + T cells. Nature communications 15 (1) (2024)
Mike Bogetofte Barnkob, Yale S Michaels, Violaine André, Philip S Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna A Kulicke, Ji-Li Chen, Vitul Jain, Victoria K Woodcock, Huw Colin-York, Andreas V Hadjinicolaou, Youxin Kong, Viveka Mayya, Julie M Mazet, Gracie-Jennah Mead, Joshua A Bull, Pramila Rijal, Christopher W Pugh, Alain R Townsend, Audrey Gerard, Lars Rønn Olsen, Marco Fritzsche, Tudor A Fulga, Michael L Dustin, Edith Yvonne Jones, Vincenzo Cerundolo
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8 + T cells. Nature communications 15 (1) (2024)
Mike Bogetofte Barnkob, Yale S Michaels, Violaine André, Philip S Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna A Kulicke, Ji-Li Chen, Vitul Jain, Victoria K Woodcock, Huw Colin-York, Andreas V Hadjinicolaou, Youxin Kong, Viveka Mayya, Julie M Mazet, Gracie-Jennah Mead, Joshua A Bull, Pramila Rijal, Christopher W Pugh, Alain R Townsend, Audrey Gerard, Lars Rønn Olsen, Marco Fritzsche, Tudor A Fulga, Michael L Dustin, Edith Yvonne Jones, Vincenzo Cerundolo
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8 + T cells. Nature communications 15 (1) (2024)
Mike Bogetofte Barnkob, Yale S Michaels, Violaine André, Philip S Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna A Kulicke, Ji-Li Chen, Vitul Jain, Victoria K Woodcock, Huw Colin-York, Andreas V Hadjinicolaou, Youxin Kong, Viveka Mayya, Julie M Mazet, Gracie-Jennah Mead, Joshua A Bull, Pramila Rijal, Christopher W Pugh, Alain R Townsend, Audrey Gerard, Lars Rønn Olsen, Marco Fritzsche, Tudor A Fulga, Michael L Dustin, Edith Yvonne Jones, Vincenzo Cerundolo
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8 + T cells. Nature communications 15 (1) (2024)
Michael Skwarski, Daniel R McGowan, Elizabeth Belcher, Francesco Di Chiara, Dionisios Stavroulias, Mark McCole, Jennifer L Derham, Kwun-Ye Chu, Eugene Teoh, Jagat Chauhan, Dawn O'Reilly, Benjamin Howell Lole Harris, Philip S Macklin, Joshua A Bull, Marcus Green, Gonzalo Rodriguez-Berriguete, Remko Prevo, Lisa K Folkes, Leticia Campo, Petra Ferencz, Paula L Croal, Helen Flight, Cathy Qi, Jane Holmes, James P B O'Connor, Fergus V Gleeson, W Gillies McKenna, Adrian L Harris, Daniel Bulte, Francesca M Buffa, Ruth E Macpherson, Geoff S Higgins
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Oliver Vipond, Joshua A Bull, Philip S Macklin, Ulrike Tillmann, Christopher W Pugh, Helen M Byrne, Heather A Harrington
Multiparameter persistent homology landscapes identify immune cell spatial patterns in tumors. Proceedings of the National Academy of Sciences of the United States of America 118 (41) (2021)
Philip S Macklin, Clare L Verrill, Ian S D Roberts, Richard Colling, Mark E Sullivan, Guy M Webster, David W Cranston, Charles R Tapping, Lisa Browning
Tumour seeding of the renal tumour biopsy tract - a histologically under-recognised feature? Histopathology 76 (5) (2020)
Philip S Macklin, Atsushi Yamamoto, Lisa Browning, Monika Hofer, Julie Adam, Christopher W Pugh
Recent advances in the biology of tumour hypoxia with relevance to diagnostic practice and tissue-based research. The Journal of pathology 250 (5) (2020)
Richard Colling, Helen Pitman, Karin Oien, Nasir Rajpoot, Philip S Macklin, null null, David Snead, Tony Sackville, Clare Verrill
Artificial intelligence in digital pathology: a roadmap to routine use in clinical practice. The Journal of pathology 249 (2) (2019)
Philip S Macklin, Andrew Hall, Jessica Lee, Jane Hair, Valerie Speirs, Gareth J Thomas, Karin A Oien, Clare Verrill
Barriers to the release of human tissue for clinical trials research in the UK: a national survey of cellular pathology laboratories on behalf of the National Cancer Research Institute's Cellular Molecular Pathology (CM-Path) initiative. Journal of clinical pathology 72 (1) (2018)

Philip S Macklin.css-eqlu8i{font-size:small;padding-left:4px;} (Philip Macklin)

Publication Activity (10 Years)

Top Topics

Top Venues

Philip S Macklin (Philip Macklin)